Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 908 shares at $115.60 ($105K) on 2026-01-21, disclosed to the SEC on 2026-01-23.
Scheduled sale ($105k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |